October 10, 2025

FDA Broadens Label for Schizophrenia Drug

The FDA has approved a new long-acting injectable treatment option for adults with bipolar I disorder.

Conexiant

October 10, 2025

Panel Finalizes 6 Cannabis Competencies For US Med Schools

New framework guides medical schools in teaching evidence-based cannabis education.

Conexiant

October 03, 2025

Autism Trajectories: What the Data Suggest

Two genetic factors may shape autism’s age of diagnosis and mental health overlap. 

Conexiant

September 29, 2025

Levodopa Investigated for Stroke Rehabilitation: ESTREL Trial

Swiss trial across 13 stroke units and 11 rehab centers challenges levodopa use in stroke recovery.

Conexiant

September 23, 2025

AI Model Predicts Multiple Disease Risk

Delphi-2M transformer, trained on nearly 2 million patients, predicts disease progression and mortality risk years in advance

Conexiant

September 18, 2025

Cuts or Care: ‘What Are the Priorities?’

New residency programs launch as Northern California faces ongoing physician shortages and potential funding reductions.

KFF Health News

September 18, 2025

Semaglutide Reduced HbA1c, Weight in Schizophrenia

First trial shows semaglutide maintains psychiatric stability while improving metabolic outcomes in patients with schizophrenia.

Conexiant

September 17, 2025

‘Death by a Thousand Cuts’

Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care.

KFF Health News

September 17, 2025

Global Survey Finds Suicidal Ideation Risk With Atopic Eczema

Obesity, severe disease, and insomnia raise suicidal ideation risk in atopic eczema

Conexiant